COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction (MARBLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03802396
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : July 14, 2020
Information provided by (Responsible Party):
Miles Berger, MD PhD, Duke University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 17, 2022
Estimated Study Completion Date : December 17, 2022